title: Reverse genetics approaches to combat pathogenic arenaviruses.
abstract: Several arenaviruses cause hemorrhagic fever (HF) in humans, and evidence indicates that the worldwide-distributed prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is a neglected human pathogen of clinical significance. Moreover, arenaviruses pose a biodefense threat. No licensed anti-arenavirus vaccines are available, and current anti-arenavirus therapy is limited to the use of ribavirin, which is only partially effective and is associated with anemia and other side effects. Therefore, it is important to develop effective vaccines and better antiviral drugs to combat the dual threats of naturally occurring and intentionally introduced arenavirus infections. The development of arenavirus reverse genetic systems is allowing investigators to conduct a detailed molecular characterization of the viral cis-acting signals and trans-acting factors that control each of the steps of the arenavirus life cycle, including RNA synthesis, packaging and budding. Knowledge derived from these studies is uncovering potential novel targets for therapeutic intervention, as well as facilitating the establishment of assays to identify and characterize candidate antiviral drugs capable of interfering with specific steps of the virus life cycle. Likewise, the ability to generate predetermined specific mutations within the arenavirus genome and analyze their phenotypic expression would significantly contribute to the elucidation of arenavirus-host interactions, including the basis of their ability to cause severe HF. This, in turn, could lead to the development of novel, potent and safe arenavirus vaccines.
authors.affiliation: Immunology and Microbial Science, IMM-6, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. juanct@scripps.edu
authors.forename: Juan C
authors.initials: JC
authors.lastname: de la Torre
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001117:Arenaviridae Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D018050:Arenavirus / Q000187:drug effects / Q000235:genetics* / Q000276:immunology / Q000502:physiology; D004353:Drug Evaluation, Preclinical; D006801:Humans; D011401:Promoter Regions, Genetic; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology*; D018406:Virus Physiological Phenomena / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D014765:Viral Vaccines
references.citation: J Virol. 1985 Sep;55(3):704-9
references.pmid: 4020963
references.citation: J Biol Chem. 2008 Jul 4;283(27):18734-42
references.pmid: 18474596
references.citation: Arch Pathol Lab Med. 1992 May;116(5):486-8
references.pmid: 1316111
references.citation: J Virol. 2004 Mar;78(6):2979-83
references.pmid: 14990716
references.citation: Clin Infect Dis. 2001 Nov 15;33(10):1707-12
references.pmid: 11595975
references.citation: Comb Chem High Throughput Screen. 2000 Jun;3(3):219-34
references.pmid: 10903381
references.citation: J Virol. 2002 Jun;76(12):6393-7
references.pmid: 12021374
references.citation: J Virol. 2000 Apr;74(8):3470-7
references.pmid: 10729120
references.citation: Mol Ther. 2005 Mar;11(3):435-43
references.pmid: 15727940
references.citation: Protein Expr Purif. 2007 Feb;51(2):308-19
references.pmid: 16973377
references.citation: J Virol. 2005 Apr;79(7):4519-26
references.pmid: 15767453
references.citation: Antimicrob Agents Chemother. 1988 Sep;32(9):1304-9
references.pmid: 2848441
references.citation: J Virol. 2003 Jan;77(2):1184-94
references.pmid: 12502835
references.citation: Nature. 2004 Mar 25;428(6981):431-7
references.pmid: 15042092
references.citation: J Virol. 2002 Jul;76(13):6678-88
references.pmid: 12050381
references.citation: J Biol Chem. 2002 Mar 29;277(13):11265-75
references.pmid: 11756446
references.citation: Science. 2001 Mar 23;291(5512):2344-50
references.pmid: 11269314
references.citation: Angew Chem Int Ed Engl. 2000 Mar;39(6):1080-1084
references.pmid: 10760928
references.citation: J Biol Chem. 2004 Aug 6;279(32):33782-90
references.pmid: 15178688
references.citation: J Hum Virol. 2001 Mar-Apr;4(2):103-8
references.pmid: 11437313
references.citation: Virology. 2003 Mar 30;308(1):37-47
references.pmid: 12706088
references.citation: Nature. 1990 Mar 29;344(6265):467-8
references.pmid: 1690861
references.citation: N Engl J Med. 2006 May 25;354(21):2235-49
references.pmid: 16723615
references.citation: J Virol. 2004 Oct;78(19):10783-92
references.pmid: 15367645
references.citation: J Virol. 2002 Jul;76(14):7263-75
references.pmid: 12072526
references.citation: Virus Res. 2005 Feb;107(2):165-71
references.pmid: 15649562
references.citation: Clin Infect Dis. 1997 Apr;24(4):718-22
references.pmid: 9145749
references.citation: Cell. 2006 Feb 10;124(3):587-99
references.pmid: 16469704
references.citation: Arch Biochem Biophys. 2002 Jan 15;397(2):139-48
references.pmid: 11795864
references.citation: J Virol. 2003 Oct;77(19):10700-5
references.pmid: 12970458
references.citation: Mol Cell. 2000 Dec;6(6):1355-64
references.pmid: 11163209
references.citation: J Virol. 2004 May;78(10):5068-78
references.pmid: 15113888
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12978-83
references.pmid: 14563923
references.citation: Virology. 2004 Jan 5;318(1):439-50
references.pmid: 14972569
references.citation: Antiviral Res. 2008 Apr;78(1):9-25
references.pmid: 18313769
references.citation: J Virol. 1991 Apr;65(4):1863-9
references.pmid: 1840619
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12701-5
references.pmid: 11606739
references.citation: J Virol. 2005 Jun;79(11):7262-8
references.pmid: 15890965
references.citation: Biochem Soc Symp. 2003;(70):221-31
references.pmid: 14587295
references.citation: Cell. 1993 Sep 24;74(6):969-78
references.pmid: 8402886
references.citation: Curr Opin Infect Dis. 2001 Dec;14(6):757-64
references.pmid: 11964896
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7895-900
references.pmid: 12808132
references.citation: Nat Med. 2004 Dec;10(12 Suppl):S110-21
references.pmid: 15577929
references.citation: J Virol. 2001 Dec;75(24):12241-51
references.pmid: 11711615
references.citation: Med Clin North Am. 1999 Jul;83(4):865-83, v
references.pmid: 10453254
references.citation: J Virol Methods. 2006 Oct;137(1):115-9
references.pmid: 16837071
references.citation: Mol Cell. 2003 Sep;12(3):627-37
references.pmid: 14527409
references.citation: Curr Opin Drug Discov Devel. 2001 Jul;4(4):462-70
references.pmid: 11727311
references.citation: Annu Rev Biochem. 2005;74:739-89
references.pmid: 15952902
references.citation: Curr Top Microbiol Immunol. 2004;283:1-41
references.pmid: 15298166
references.citation: Cell. 1989 Dec 22;59(6):1107-13
references.pmid: 2598262
references.citation: Curr Top Microbiol Immunol. 2002;262:139-57
references.pmid: 11987804
references.citation: J Virol. 2005 Sep;79(17):11071-81
references.pmid: 16103158
references.citation: PLoS Pathog. 2006 Jun;2(6):e51
references.pmid: 16751848
references.citation: J Virol. 2005 Jun;79(11):6890-9
references.pmid: 15890928
references.citation: Angew Chem Int Ed Engl. 1999 Aug;38(16):2300-2324
references.pmid: 10458780
references.citation: J Gen Virol. 2002 Nov;83(Pt 11):2635-2662
references.pmid: 12388800
references.citation: Curr Top Microbiol Immunol. 2002;263:239-61
references.pmid: 11987817
references.citation: J Virol. 2001 Dec;75(23):11677-85
references.pmid: 11689649
references.citation: Science. 1990 Aug 3;249(4968):505-10
references.pmid: 2200121
references.citation: FEBS Lett. 2004 Aug 27;573(1-3):186-94
references.pmid: 15327996
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1321-6
references.pmid: 9990022
references.citation: J Biol Chem. 1998 Mar 6;273(10):5785-93
references.pmid: 9488713
references.citation: Virology. 2002 Dec 20;304(2):235-45
references.pmid: 12504565
references.citation: J Virol. 2003 Aug;77(16):8640-9
references.pmid: 12885882
references.citation: J Virol. 2006 Dec;80(24):12414-9
references.pmid: 17005649
references.citation: Virus Res. 1992 Mar;22(3):185-98
references.pmid: 1626415
references.citation: J Virol. 2008 Jun;82(12):6045-51
references.pmid: 18400865
references.citation: Cell. 1997 May 2;89(3):331-40
references.pmid: 9150132
references.citation: Biochemistry. 1998 Apr 21;37(16):5549-57
references.pmid: 9548939
references.citation: Curr Med Chem. 2002 May;9(9):929-39
references.pmid: 11966454
references.citation: N Engl J Med. 2006 May 25;354(21):2208-11
references.pmid: 16723613
references.citation: Am J Obstet Gynecol. 2002 Dec;187(6):1715-6
references.pmid: 12501090
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4663-8
references.pmid: 16537369
references.citation: Pediatr Infect Dis J. 1999 Jun;18(6):540-1
references.pmid: 10391186
references.citation: J Biol Chem. 2004 Apr 23;279(17):17338-47
references.pmid: 14970232
references.citation: J Virol. 2000 Aug;74(15):6777-83
references.pmid: 10888616
references.citation: J Virol. 2005 Mar;79(6):3822-30
references.pmid: 15731275
references.citation: Curr Top Microbiol Immunol. 2002;263:83-117
references.pmid: 11987822
references.citation: Am J Ophthalmol. 2000 Aug;130(2):209-15
references.pmid: 11004296
references.citation: Curr Med Chem. 2000 Jan;7(1):73-98
references.pmid: 10637358
references.citation: Nature. 1990 Aug 30;346(6287):818-22
references.pmid: 1697402
references.citation: J Virol. 2007 Oct;81(20):10981-90
references.pmid: 17670839
references.citation: Curr Top Microbiol Immunol. 2002;262:111-37
references.pmid: 11987803
references.citation: PLoS Med. 2005 Jun;2(6):e183
references.pmid: 15971954
references.citation: Virology. 2003 Sep 15;314(1):168-78
references.pmid: 14517070
references.citation: Microbes Infect. 1999 Jul;1(8):609-14
references.pmid: 10611737
references.citation: Curr Top Microbiol Immunol. 2002;263:1-5
references.pmid: 11987811
references.citation: Clin Infect Dis. 2001 Aug 1;33(3):370-4
references.pmid: 11438904
references.citation: Antiviral Res. 1993 Sep;22(1):45-75
references.pmid: 8250543
references.citation: J Virol. 2002 May;76(10):4679-87
references.pmid: 11967285
references.citation: J Virol. 2004 Oct;78(20):11443-8
references.pmid: 15452271
references.citation: Nat Med. 2000 Dec;6(12):1375-9
references.pmid: 11100123
references.citation: Curr Top Microbiol Immunol. 2002;262:65-74
references.pmid: 11987808
references.citation: Adv Virus Res. 2002;58:125-55
references.pmid: 12205778
references.citation: J Virol. 2003 Dec;77(23):12617-29
references.pmid: 14610184
references.citation: J Virol. 2003 Mar;77(6):3578-85
references.pmid: 12610133
references.citation: J Virol. 2002 May;76(9):4162-71
references.pmid: 11932381
references.citation: Lancet. 1979 Oct 6;2(8145):738
references.pmid: 90819
references.citation: Virology. 2006 Jul 5;350(2):370-80
references.pmid: 16476461
references.citation: Antiviral Res. 2008 Apr;78(1):103-15
references.pmid: 18241935
references.citation: Science. 1999 Apr 23;284(5414):611-5
references.pmid: 10213678
references.citation: Antiviral Res. 1996 Jul;31(3):149-58
references.pmid: 8811199
references.citation: EMBO J. 1989 Dec 1;8(12):3867-74
references.pmid: 2555175
references.citation: Nat Rev Mol Cell Biol. 2003 Aug;4(8):631-40
references.pmid: 12923525
references.citation: J Virol. 1976 Oct;20(1):157-69
references.pmid: 185410
references.citation: J Biol Chem. 2006 Aug 18;281(33):23471-81
references.pmid: 16790437
references.citation: Antiviral Res. 2006 Feb;69(2):86-97
references.pmid: 16343651
references.citation: EMBO Rep. 2003 Nov;4(11):1084-8
references.pmid: 14555961
references.citation: J Virol. 2005 Nov;79(22):13934-42
references.pmid: 16254329
references.citation: J Biol Chem. 2004 Mar 26;279(13):12293-9
references.pmid: 14709548
references.citation: Nature. 2004 Mar 25;428(6981):427-31
references.pmid: 15042091
references.citation: Antiviral Res. 1990 Oct-Nov;14(4-5):287-99
references.pmid: 2088208
references.citation: J Virol. 2003 Mar;77(6):3882-7
references.pmid: 12610166
references.citation: Bioorg Med Chem Lett. 1998 Sep 8;8(17):2339-44
references.pmid: 9873538
references.citation: Antivir Chem Chemother. 2000 Jan;11(1):71-7
references.pmid: 10693656
references.citation: J Virol. 2001 Oct;75(19):9415-26
references.pmid: 11533204
references.citation: JAMA. 2002 May 8;287(18):2391-405
references.pmid: 11988060
references.citation: Virology. 2005 Apr 25;335(1):87-98
references.pmid: 15823608
references.citation: J Biomol Screen. 2005 Aug;10(5):476-84
references.pmid: 16093557
references.citation: Virus Res. 2007 Mar;124(1-2):237-44
references.pmid: 17125871
references.citation: J Virol. 2007 Sep;81(17):9451-60
references.pmid: 17581989
references.citation: Bioorg Med Chem. 2003 Apr 17;11(8):1607-13
references.pmid: 12659745
references.citation: J Virol. 2003 Mar;77(5):2866-72
references.pmid: 12584310
references.citation: Annu Rev Biochem. 1996;65:609-34
references.pmid: 8811191
references.citation: Angew Chem Int Ed Engl. 2003 Sep 15;42(35):4138-76
references.pmid: 14502729
references.citation: J Exp Med. 1990 Oct 1;172(4):1043-8
references.pmid: 2212940
references.citation: Antiviral Res. 2008 Apr;78(1):132-9
references.pmid: 18054395
references.citation: Curr Opin Chem Biol. 2000 Dec;4(6):678-86
references.pmid: 11102874
references.citation: J Virol. 2006 Apr;80(8):4191-5
references.pmid: 16571837
references.citation: J Virol. 2007 Oct;81(20):10849-60
references.pmid: 17686866
references.citation: Angew Chem Int Ed Engl. 2000 Jun 2;39(11):1890-1904
references.pmid: 10940979
references.citation: J Infect Dis. 1998 Feb;177(2):277-83
references.pmid: 9466512
references.citation: Virology. 1985 Apr 15;142(1):175-82
references.pmid: 4060570
references.citation: Trends Cell Biol. 2002 Dec;12(12):569-79
references.pmid: 12495845
references.citation: N Engl J Med. 1990 Oct 18;323(16):1120-3
references.pmid: 2215580
references.citation: Neurology. 2006 Jan 24;66(2 Suppl 1):S102-9
references.pmid: 16432136
references.citation: Virus Res. 2001 Jan;73(1):41-55
references.pmid: 11163643
references.citation: J Virol. 2004 Dec;78(24):13793-803
references.pmid: 15564487
references.citation: N Engl J Med. 1986 Jan 2;314(1):20-6
references.pmid: 3940312